| Sofia Khalil, MD | |
|
25 N Winfield Rd Ste 400, Winfield, IL 60190-1379 | |
| (630) 456-7178 | |
| (630) 456-7486 |
| Full Name | Sofia Khalil |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 25 N Winfield Rd Ste 400, Winfield, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477879880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 036132936 (Illinois) | Primary |
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.
Researchers at Emory University School of Medicine have identified five rare mutations in a single gene that appear to increase the chances that a boy will develop an autism spectrum disorder (ASD).
Hui Shao, MD, PhD, associate professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received a $60,000 Lew R. Wasserman Merit Award from the Research to Prevent Blindness (RPB) organization. The grant will help fund Shao's research of Sjogren's syndrome, a chronic autoimmune disease that targets the salivary and lacrimal glands - the glands that produce saliva and tears, respectively - resulting in dry mouth and dry eye symptoms.
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sofia Khalil, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Sofia Khalil, MD 25 N Winfield Rd Ste 400, Winfield, IL 60190-1379 Ph: (630) 456-7178 |
News Archive
Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.
Researchers at Emory University School of Medicine have identified five rare mutations in a single gene that appear to increase the chances that a boy will develop an autism spectrum disorder (ASD).
Hui Shao, MD, PhD, associate professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received a $60,000 Lew R. Wasserman Merit Award from the Research to Prevent Blindness (RPB) organization. The grant will help fund Shao's research of Sjogren's syndrome, a chronic autoimmune disease that targets the salivary and lacrimal glands - the glands that produce saliva and tears, respectively - resulting in dry mouth and dry eye symptoms.
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
› Verified 5 days ago
Timothy R Long, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Sarah Jaber, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Ms. Julia Kochel Hernandez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Ste 400, Winfield, IL 60190 Phone: 630-469-9200 | |
Lipi Mehul Sekhadia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 | |
Dr. Nicolai E Hinds, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-653-4240 Fax: 630-315-6597 | |
Priya Venkataraman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Dr. Sana Sajid Chaudhry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 |